Ownership history in BlackBarn Capital Partners LP Β· 9 quarters on record
This page tracks every 13F SEC filing in which BlackBarn Capital Partners LP reported a position in PRIVIA HEALTH GROUP INC (PRVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π BlackBarn Capital Partners LP underperformed the S&P 500 by β4.7% annually on this PRVA position. Timing score: 60% (3/5 decisions correct). Average cost basis: $21.71. Maximum drawdown during holding period: β11.3%.
β οΈ Trailed SPY by 4.7% ann. on this position.
7 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
3 of 5 add/trim decisions correct
Best entry: $17.38 (2024 Q2) Β· Worst: $24.90 (2025 Q3)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
7 adds Β· 0 trims. Bought during 2 of 2 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π BlackBarn Capital Partners LP has been actively increasing its PRVA allocation β a bullish signal from insiders.
Currently 2.03% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size